# Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon

> **NCT00951106** · NA · COMPLETED · sponsor: **Walter Reed Army Institute of Research (WRAIR)**

## Conditions studied

- Malaria, Vivax
- Malaria, Falciparum

## Interventions

- **DRUG:** Pyrimethamine/sulfdoxine (Fansidar)

## Key facts

- **NCT ID:** NCT00951106
- **Lead sponsor:** Walter Reed Army Institute of Research (WRAIR)
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** 1999-06
- **Final completion:** 2009-08
- **Target enrollment:** — (—)
- **Last updated:** 2010-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951106, "Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00951106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*